特罗吉根素通过靶向EGFR-EGR2-Acot1轴来改善心肌脂质代谢,从而缓解射血分数保留型心力衰竭(HFpEF)症状。
Tectorigenin alleviates HFpEF by targeting the EGFR-EGR2-Acot1 axis to improve myocardial lipid metabolism
Wang Li-guo, Lin Ke, You Meng-zhen, Li Qin-feng, Wei Wen-jie, Li Hui, Shi Yi, Yan Yu-feng, Li Ran, Wang Mei-hui, Xia Chun-lei, Fu Guo-sheng, Xu Ya-ting
Journal:ACTA PHARMACOLOGICA SINICA
IF:10.4
DOI:10.1038/s41401-026-01926-2
PMID:42760346
Published:2026-09-18
research field:呼吸生物学
Abstract
Heart failure with preserved ejection fraction (HFpEF) accounts for approximately 50% of all heart failure cases worldwide, yet effective targeted therapies remain limited. Tectorigenin (Tec), a bioactive isoflavone derived from traditional Chinese medicine, exhibits diverse cardioprotective effects; however, its therapeutic potential and underlying mechanisms in HFpEF remain incompletely understood. This study aimed to investigate the effects of Tec on HFpEF and elucidate the underlying molecular mechanisms. A mouse model of HFpEF was established using the “two-hit” approach (high-fat diet + L -NAME). In vivo experiments included echocardiography, histological staining, treadmill testing, metabolic assessments, and molecular analyses. In vitro, neonatal rat ventricular myocytes (NRVMs) exposed to palmitic acid (PA) were used to model cardiomyocyte lipotoxicity. RNA sequencing, network pharmacology, molecular docking, surface plasmon resonance, pull-down assays, chromatin immunoprecipitation, and gene silencing were employed to elucidate the regulatory mechanisms. Tec attenuated HFpEF progression and retained therapeutic efficacy when administered after HFpEF establishment. In vitro, Tec alleviated PA-induced cardiomyocyte lipotoxicity. Mechanistically, Tec directly bound EGFR at the E762/M793 sites and inhibited its aberrant activation. Inhibition of EGFR signaling suppressed the downstream EGFR-EGR2 axis, thereby upregulating Acot1 and improving myocardial lipid metabolic homeostasis. Cardiac-specific Acot1 knockdown or pharmacological activation of EGFR markedly attenuated Tec-mediated improvements in cardiac function, remodeling, and myocardial lipid metabolism. Tec ameliorates HFpEF through the EGFR-EGR2-Acot1 axis, highlighting a potential therapeutic strategy for HFpEF.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


